IRIDEX Corporation
IRIDEX Corporation, founded in 1989, is a worldwide leader in developing, manufacturing, and marketing innovative and versatile light-based medical systems and delivery devices, 
IRIDEX has pioneered research, collaborated with physicians, and developed products to perform gentler laser therapy for the treatment of eye diseases. IRIDEX laser systems are used to treat the three leading causes of irreversible blindness: age-related macular degeneration, diabetic retinopathy, and glaucoma.
810 nm Lasers
The IQ810 laser system is the state-of-the-art system designed to perform traditional and MicroPulse procedures for retinal disorders and next-generation therapy for the treatment of glaucoma.
577 nm Lasers
The IQ 577 laser system is the first visible wavelength laser to incorporate MicroPulse™ technology. It offers a high-power, true yellow wavelength with peak absorption in hemoglobin.
532 nm Lasers
The IRIDEX 532 nm laser systems, indicated for retinal photocoagulation and the treatment of glaucoma, encompass the latest in solid-state technology. They are widely accepted for their reliability, performance, ease of use, and portability.
Combination Systems
The Symphony is the first laser delivery system to offer the clinical versatility and convenience of 532 nm, 810 nm and large spot 810 nm in one well-orchestrated device. All IRIDEX delivery devices are compatible with the Symphony system.
Delivery Devices
A wide selection of delivery devices has been developed to provide the physician with treatment alternatives for a variety of clinical procedures.
EndoProbe
There are dozens of IRIDEX EndoProbe models designed with quality and ergonomics in mind. For the best endophotocoagulation treatment options, simply choose your size: 20-, 23-, or 25-gauge; and choose your style: straight, angled, stepped, aspirating, illuminating, or adjustable and intuitive.
.jpg){kind=logo}
